Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer

Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer

Immunotherapy with immune checkpoint inhibitors (ICI) has recently become a standard part of the treatment of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), although the response rates are low. Numerous preclinical and clinical studies have now illuminated several mechani...

Full description

Bibliographic Details
Main Authors: Gaber Plavc, Tanja Jesenko, Miha Oražem, Primož Strojan
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
head and neck neoplasms
immunoradiotherapy
SBRT
immunotherapy
abscopal effect
Online Access:https://www.mdpi.com/2072-6694/12/11/3197

Similar Items

Similar Items